A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL) - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00073489

Locations


United States, Arizona
	Arizona Hematology & Oncology Associates
	Phoenix, Arizona, United States, 85012

United States, Colorado
	Rocky Mountain Cancer Centers
	Aurora, Colorado, United States, 80012

United States, Florida
	Florida Oncology Associates
	Jacksonville, Florida, United States, 32207
	Ocala Oncology Center
	Ocala, Florida, United States, 34474

United States, Iowa
	Iowa Oncology Associates
	Cedar Rapids, Iowa, United States, 52403

United States, Missouri
	Oncology/Hematology Associates of Kansas City
	Kansas City, Missouri, United States, 64111

United States, North Carolina
	Piedmont Hem Onc Assoc, P.A.
	Winston Salem, North Carolina, United States, 27103

United States, Ohio
	Dayton Oncology/Hematology Consultants
	Dayton, Ohio, United States, 45439

United States, Oregon
	Willamette Valley Cancer Center
	Eugene, Oregon, United States, 97401

United States, South Carolina
	Cancer Centers of the Carolinas
	Greenville, South Carolina, United States, 29615

United States, Texas
	Tyler Cancer Center
	Tyler, Texas, United States, 75702
	Southwest Regional Cancer Center
	Austin, Texas, United States, 78705
	Hematology Oncology Associates of South Texas
	San Antonio, Texas, United States, 78229

United States, Virginia
	Oncology & Hematology Associates of Southwest Virginia
	Roanoke, Virginia, United States, 24101

United States, Washington
	Cancer Care Northwest
	Spokane, Washington, United States, 99202

Sponsors and Collaborators

OSI Pharmaceuticals